Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Li Y, Wang X, Blau DM, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047–64.
2. Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, et al. Respiratory syncytial virus seasonality: a global overview. J Infect Dis. 2018;217(9):1356–64.
3. Eichinger KM, Kosanovich JL, Lipp M, et al. Strategies for active and passive pediatric RSV immunization. Ther Adv Vaccines Immunother. 2021;9:1–21.
4. Esposito S, Abu Raya B, Baraldi E, et al. RSV prevention in all infants: which is the most preferable strategy? Front Immunol. 2022;13(880368):1–13.
5. Principi N, Autore G, Perrone S, et al. Current and emerging pharmacotherapy for respiratory syncytial virus (RSV) infection in infants. Expert Opin Pharmacother. 2023;24(6):747–62.